Cargando…
Parallel Evolution to Elucidate the Contributions of PA0625 and parE to Ciprofloxacin Sensitivity in Pseudomonas aeruginosa
Pseudomonas aeruginosa is a ubiquitous pathogen that causes a wide range of acute and chronic infections. Ciprofloxacin, one of the first-line fluoroquinolone class antibiotics, is commonly used for the treatment of P. aeruginosa infections. However, ciprofloxacin-resistant P. aeruginosa is increasi...
Autores principales: | Liu, Qi, Yin, Liwen, Lv, Chenjing, Bai, Fang, Cheng, Zhihui, Wu, Weihui, Jin, Yongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860795/ https://www.ncbi.nlm.nih.gov/pubmed/36677304 http://dx.doi.org/10.3390/microorganisms11010013 |
Ejemplares similares
-
Mechanisms for Development of Ciprofloxacin Resistance in a Clinical Isolate of Pseudomonas aeruginosa
por: Xu, Congjuan, et al.
Publicado: (2021) -
MvaT binds to the P
(exsC)
promoter to repress the type III secretion system in Pseudomonas aeruginosa
por: Yin, Liwen, et al.
Publicado: (2023) -
PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
por: Tan, Hao, et al.
Publicado: (2016) -
Pseudomonas aeruginosa Polynucleotide Phosphorylase Contributes to Ciprofloxacin Resistance by Regulating PrtR
por: Fan, Zheng, et al.
Publicado: (2019) -
Reversion of Ceftazidime Resistance in Pseudomonas aeruginosa under Clinical Setting
por: Liu, Qi, et al.
Publicado: (2022)